Join Amanda Forys at the World Orphan Drug Congress USA 2025

Optimizing Market Access Strategies for Orphan Drugs

The World Orphan Drug Congress USA 2025 is the leading global event dedicated to the orphan drug and rare disease industry, attracting over 2,000 participants including industry executives, government and regulatory bodies, patient advocates, investors, and solution providers. Over three days, attendees will explore innovative strategies and critical issues influencing rare disease treatment, drug pricing, reimbursement, commercialization, and patient access.

Featured Speaker:

Amanda Forys

Managing Partner, Magnolia Market Access

Amanda Forys brings deep expertise in strategic market access and reimbursement solutions, with a specialized focus on orphan drugs and rare disease therapies. Her leadership at Magnolia Market Access has consistently delivered impactful strategies that drive successful commercialization and patient access.

Tree icon surrounded by circle graph

Optimizing Strategies for Orphan Drug Access and Reimbursement: Considerations for Raising Venture Capital through Commercialization

In this critical discussion, Amanda and fellow panelists will provide expert perspectives on:

  • Strategies to optimize market access, pricing, and reimbursement specifically tailored for orphan drugs.
  • Insights into successful multi-stakeholder engagement from early drug development stages through commercialization.
  • Approaches to attract venture capital investment by demonstrating robust commercialization plans aligned with stakeholder expectations.
  • Addressing key challenges in creating sustainable, value-driven access strategies across orphan therapeutic areas.

Additional Panelists Include:

  • Steve St. Onge, SVP – Corporate Development, Clarametyx Biosciences
  • Doug Paul, VP Commercial Strategy, Cypress Biopharma
  • Ted Slocomb, VP Global Commercial Strategy, Value & Access, Kite Pharma
  • Jim Coccia, Partner, TKG Access

Schedule a one-on-one meeting with the Magnolia Market Access team to discuss customized market access solutions tailored to your organization’s unique challenges.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.